{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:50:53Z","timestamp":1795027853164,"version":"4.10.2"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T00:00:00Z","timestamp":1646784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T00:00:00Z","timestamp":1646784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["NRF 2020R1I1A3A04037055"],"award-info":[{"award-number":["NRF 2020R1I1A3A04037055"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["NRF-2019R1I1A3A010638331"],"award-info":[{"award-number":["NRF-2019R1I1A3A010638331"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["NRF 2017R1A6A1A03015713"],"award-info":[{"award-number":["NRF 2017R1A6A1A03015713"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["NRF-2021R1I1A1A01059870"],"award-info":[{"award-number":["NRF-2021R1I1A1A01059870"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Fabry disease (FD) is a lysosome storage disease (LSD) characterized by significantly reduced intracellular autophagy function. This contributes to the progression of intracellular pathologic signaling and can lead to organ injury. Phospholipid\u2013polyethyleneglycol-capped Ceria-Zirconia antioxidant nanoparticles (PEG-CZNPs) have been reported to enhance autophagy flux. We analyzed whether they suppress globotriaosylceramide (Gb3) accumulation by enhancing autophagy flux and thereby attenuate kidney injury in both cellular and animal models of FD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Gb3 was significantly increased in cultured human renal proximal tubular epithelial cells (HK-2) and human podocytes following the siRNA silencing of \u03b1 galactosidase A (\u03b1-GLA). PEG-CZNPs effectively reduced the intracellular accumulation of Gb3 in both cell models of FD and improved both intracellular inflammation and apoptosis in the HK-2 cell model of FD. Moreover these particles attenuated pro fibrotic cytokines in the human podocyte model of FD. This effect was revealed through an improvement of the intracellular autophagy flux function and a reduction in reactive oxygen species (ROS). An FD animal model was generated in which 4-week-old male<jats:italic>B6;129-Gla<\/jats:italic><jats:sup><jats:italic>tm1Kul<\/jats:italic><\/jats:sup>\/J mice were treated for 8\u00a0weeks with 10\u00a0mg\/kg of PEG-CZNPs (twice weekly via intraperitoneal injection). Gb3 levels were reduced in the kidney tissues of these animals, and their podocyte characteristics and autophagy flux functions were preserved.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>PEG-CZNPs alleviate FD associated kidney injury by enhancing autophagy function and thus provide a foundation for the development of new drugs to treat of storage disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Graphical Abstract<\/jats:title><\/jats:sec>","DOI":"10.1186\/s12951-022-01318-8","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T11:03:11Z","timestamp":1646823791000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Ceria-Zirconia nanoparticles reduce intracellular globotriaosylceramide accumulation and attenuate kidney injury by enhancing the autophagy flux in cellular and animal models of Fabry disease"],"prefix":"10.1186","volume":"20","author":[{"given":"Jong Hun","family":"An","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Eun","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong-Lan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaeku","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Gyo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoi Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Ki","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Chul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwan-Woo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won-Min","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Ro","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moon Hyang","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuk Ro","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7326-3264","authenticated-orcid":false,"given":"Se-Hee","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,9]]},"reference":[{"issue":"4","key":"1318_CR1","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.ymgme.2018.02.014","volume":"123","author":"A Ortiz","year":"2018","unstructured":"Ortiz A, Germain DP, Desnick RJ, Politei J, Mauer M, Burlina A, et al. Fabry disease revisited: management and treatment recommendations for adult patients. Mol Genet Metab. 2018;123(4):416\u201327.","journal-title":"Mol Genet Metab"},{"key":"1318_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1750-1172-5-30","volume":"5","author":"DP Germain","year":"2010","unstructured":"Germain DP. Fabry disease. Orphanet J Rare Dis. 2010;5:30.","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"1318_CR3","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1002\/humu.21074","volume":"30","author":"WL Hwu","year":"2009","unstructured":"Hwu WL, Chien YH, Lee NC, Chiang SC, Dobrovolny R, Huang AC, et al. Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c936+919G>A (IVS4+919G>A). Hum Mutat. 2009;30(10):1397\u2013405.","journal-title":"Hum Mutat"},{"issue":"11","key":"1318_CR4","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1097\/GIM.0b013e3181bb05bb","volume":"11","author":"S Waldek","year":"2009","unstructured":"Waldek S, Patel MR, Banikazemi M, Lemay R, Lee P. Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry. Genet Med. 2009;11(11):790\u20136.","journal-title":"Genet Med"},{"issue":"21","key":"1318_CR5","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","volume":"285","author":"R Schiffmann","year":"2001","unstructured":"Schiffmann R, Kopp JB, Austin HA 3rd, Sabnis S, Moore DF, Weibel T, et al. Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA. 2001;285(21):2743\u20139.","journal-title":"JAMA"},{"issue":"4","key":"1318_CR6","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/joim.12077","volume":"274","author":"F Weidemann","year":"2013","unstructured":"Weidemann F, Niemann M, Stork S, Breunig F, Beer M, Sommer C, et al. Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications. J Intern Med. 2013;274(4):331\u201341.","journal-title":"J Intern Med"},{"issue":"1","key":"1318_CR7","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1681\/ASN.2014121226","volume":"27","author":"M Lenders","year":"2016","unstructured":"Lenders M, Stypmann J, Duning T, Schmitz B, Brand SM, Brand E. Serum-mediated inhibition of enzyme replacement therapy in Fabry disease. J Am Soc Nephrol. 2016;27(1):256\u201364.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"1318_CR8","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s40265-019-01090-4","volume":"79","author":"EH McCafferty","year":"2019","unstructured":"McCafferty EH, Scott LJ. Migalastat: a review in Fabry disease. Drugs. 2019;79(5):543\u201354.","journal-title":"Drugs"},{"issue":"4","key":"1318_CR9","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/gim.2016.122","volume":"19","author":"ER Benjamin","year":"2017","unstructured":"Benjamin ER, Della Valle MC, Wu X, Katz E, Pruthi F, Bond S, et al. The validation of pharmacogenetics for the identification of Fabry patients to be treated with migalastat. Genet Med. 2017;19(4):430\u20138.","journal-title":"Genet Med"},{"issue":"3","key":"1318_CR10","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/jimd.12080","volume":"42","author":"R Schiffmann","year":"2019","unstructured":"Schiffmann R, Goker-Alpan O, Holida M, Giraldo P, Barisoni L, Colvin RB, et al. Pegunigalsidase alfa, a novel PEGylated enzyme replacement therapy for Fabry disease, provides sustained plasma concentrations and favorable pharmacodynamics: A 1-year Phase 1\/2 clinical trial. J Inherit Metab Dis. 2019;42(3):534\u201344.","journal-title":"J Inherit Metab Dis"},{"issue":"12","key":"1318_CR11","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1358\/dot.2019.55.12.3107705","volume":"55","author":"K Kunnemann","year":"2019","unstructured":"Kunnemann K. 10th world orphan drug congress (WODC) (November 12\u201314, 2019\u2014Barcelona, Spain). Drugs Today (Barc). 2019;55(12):753\u20138.","journal-title":"Drugs Today (Barc)"},{"key":"1318_CR12","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.omtm.2020.07.002","volume":"18","author":"M Yasuda","year":"2020","unstructured":"Yasuda M, Huston MW, Pagant S, Gan L, St Martin S, Sproul S, et al. AAV2\/6 gene therapy in a murine model of Fabry disease results in Supraphysiological enzyme activity and effective substrate reduction. Mol Ther Methods Clin Dev. 2020;18:607\u201319.","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"4","key":"1318_CR13","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.ymthe.2019.03.001","volume":"27","author":"F DeRosa","year":"2019","unstructured":"DeRosa F, Smith L, Shen Y, Huang Y, Pan J, Xie H, et al. Improved efficacy in a Fabry disease model using a systemic mRNA liver depot system as compared to enzyme replacement therapy. Mol Ther J Am Soc Gene Ther. 2019;27(4):878\u201389.","journal-title":"Mol Ther J Am Soc Gene Ther"},{"issue":"4","key":"1318_CR14","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ekir.2019.11.013","volume":"5","author":"A Felis","year":"2020","unstructured":"Felis A, Whitlow M, Kraus A, Warnock DG, Wallace E. Current and investigational therapeutics for Fabry disease. Kidney Int Rep. 2020;5(4):407\u201313.","journal-title":"Kidney Int Rep"},{"issue":"19","key":"1318_CR15","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1093\/hmg\/ddy248","volume":"27","author":"RWD Welford","year":"2018","unstructured":"Welford RWD, Muhlemann A, Garzotti M, Rickert V, Groenen PMA, Morand O, et al. Glucosylceramide synthase inhibition with lucerastat lowers globotriaosylceramide and lysosome staining in cultured fibroblasts from Fabry patients with different mutation types. Hum Mol Genet. 2018;27(19):3392\u2013403.","journal-title":"Hum Mol Genet"},{"issue":"5","key":"1318_CR16","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/jimd.12228","volume":"43","author":"SJ van der Veen","year":"2020","unstructured":"van der Veen SJ, Hollak CEM, van Kuilenburg ABP, Langeveld M. Developments in the treatment of Fabry disease. J Inherit Metab Dis. 2020;43(5):908\u201321.","journal-title":"J Inherit Metab Dis"},{"issue":"10","key":"1318_CR17","doi-asserted-by":"publisher","first-page":"dmm038596","DOI":"10.1242\/dmm.038596","volume":"12","author":"RA Brown","year":"2019","unstructured":"Brown RA, Voit A, Srikanth MP, Thayer JA, Kingsbury TJ, Jacobson MA, et al. mTOR hyperactivity mediates lysosomal dysfunction in Gaucher\u2019s disease iPSC-neuronal cells. Dis Model Mech. 2019;12(10):dmm038596.","journal-title":"Dis Model Mech"},{"issue":"5","key":"1318_CR18","doi-asserted-by":"publisher","first-page":"e63506","DOI":"10.1371\/journal.pone.0063506","volume":"8","author":"MC Liebau","year":"2013","unstructured":"Liebau MC, Braun F, Hopker K, Weitbrecht C, Bartels V, Muller RU, et al. Dysregulated autophagy contributes to podocyte damage in Fabry\u2019s disease. PLoS ONE. 2013;8(5):e63506.","journal-title":"PLoS ONE"},{"issue":"4","key":"1318_CR19","first-page":"269","volume":"1861","author":"C Ward","year":"2016","unstructured":"Ward C, Martinez-Lopez N, Otten EG, Carroll B, Maetzel D, Singh R, et al. Autophagy, lipophagy and lysosomal lipid storage disorders. Biochem Biophys Acta. 2016;1861(4):269\u201384.","journal-title":"Biochem Biophys Acta"},{"issue":"5","key":"1318_CR20","doi-asserted-by":"publisher","first-page":"719","DOI":"10.4161\/auto.19469","volume":"8","author":"AP Lieberman","year":"2012","unstructured":"Lieberman AP, Puertollano R, Raben N, Slaugenhaupt S, Walkley SU, Ballabio A. Autophagy in lysosomal storage disorders. Autophagy. 2012;8(5):719\u201330.","journal-title":"Autophagy"},{"issue":"5","key":"1318_CR21","doi-asserted-by":"publisher","first-page":"589","DOI":"10.4161\/auto.6.5.11943","volume":"6","author":"M Chevrier","year":"2010","unstructured":"Chevrier M, Brakch N, Celine L, Genty D, Ramdani Y, Moll S, et al. Autophagosome maturation is impaired in Fabry disease. Autophagy. 2010;6(5):589\u201399.","journal-title":"Autophagy"},{"issue":"1","key":"1318_CR22","doi-asserted-by":"publisher","first-page":"e0210617","DOI":"10.1371\/journal.pone.0210617","volume":"14","author":"MM Ivanova","year":"2019","unstructured":"Ivanova MM, Changsila E, Iaonou C, Goker-Alpan O. Impaired autophagic and mitochondrial functions are partially restored by ERT in Gaucher and Fabry diseases. PLoS ONE. 2019;14(1):e0210617.","journal-title":"PLoS ONE"},{"issue":"3","key":"1318_CR23","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.devcel.2011.07.016","volume":"21","author":"DL Medina","year":"2011","unstructured":"Medina DL, Fraldi A, Bouche V, Annunziata F, Mansueto G, Spampanato C, et al. Transcriptional activation of lysosomal exocytosis promotes cellular clearance. Dev Cell. 2011;21(3):421\u201330.","journal-title":"Dev Cell"},{"issue":"5","key":"1318_CR24","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/emmm.201202176","volume":"5","author":"C Spampanato","year":"2013","unstructured":"Spampanato C, Feeney E, Li L, Cardone M, Lim JA, Annunziata F, et al. Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease. EMBO Mol Med. 2013;5(5):691\u2013706.","journal-title":"EMBO Mol Med"},{"issue":"8","key":"1318_CR25","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.4161\/auto.6.8.13378","volume":"6","author":"N Raben","year":"2010","unstructured":"Raben N, Schreiner C, Baum R, Takikita S, Xu S, Xie T, et al. Suppression of autophagy permits successful enzyme replacement therapy in a lysosomal storage disorder\u2013murine Pompe disease. Autophagy. 2010;6(8):1078\u201389.","journal-title":"Autophagy"},{"key":"1318_CR26","doi-asserted-by":"publisher","first-page":"5131","DOI":"10.2147\/IJN.S71074","volume":"9","author":"J Duan","year":"2014","unstructured":"Duan J, Yu Y, Yu Y, Li Y, Wang J, Geng W, et al. Silica nanoparticles induce autophagy and endothelial dysfunction via the PI3K\/Akt\/mTOR signaling pathway. Int J Nanomedicine. 2014;9:5131\u201341.","journal-title":"Int J Nanomedicine"},{"issue":"7","key":"1318_CR27","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1021\/nn302235u","volume":"6","author":"S Hussain","year":"2012","unstructured":"Hussain S, Al-Nsour F, Rice AB, Marshburn J, Yingling B, Ji Z, et al. Cerium dioxide nanoparticles induce apoptosis and autophagy in human peripheral blood monocytes. ACS Nano. 2012;6(7):5820\u20139.","journal-title":"ACS Nano"},{"issue":"10","key":"1318_CR28","doi-asserted-by":"publisher","first-page":"10328","DOI":"10.1021\/nn505073u","volume":"8","author":"W Song","year":"2014","unstructured":"Song W, Soo Lee S, Savini M, Popp L, Colvin VL, Segatori L. Ceria nanoparticles stabilized by organic surface coatings activate the lysosome-autophagy system and enhance autophagic clearance. ACS Nano. 2014;8(10):10328\u201342.","journal-title":"ACS Nano"},{"issue":"8","key":"1318_CR29","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1080\/17435390.2016.1189614","volume":"10","author":"BH Mao","year":"2016","unstructured":"Mao BH, Tsai JC, Chen CW, Yan SJ, Wang YJ. Mechanisms of silver nanoparticle-induced toxicity and important role of autophagy. Nanotoxicology. 2016;10(8):1021\u201340.","journal-title":"Nanotoxicology"},{"issue":"2","key":"1318_CR30","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1021\/acsnano.7b06934","volume":"12","author":"B Villeret","year":"2018","unstructured":"Villeret B, Dieu A, Straube M, Solhonne B, Miklavc P, Hamadi S, et al. Silver nanoparticles impair retinoic acid-inducible gene I-mediated mitochondrial antiviral immunity by blocking the autophagic flux in lung epithelial cells. ACS Nano. 2018;12(2):1188\u2013202.","journal-title":"ACS Nano"},{"issue":"38","key":"1318_CR31","doi-asserted-by":"publisher","first-page":"11399","DOI":"10.1002\/anie.201704904","volume":"56","author":"M Soh","year":"2017","unstructured":"Soh M, Kang DW, Jeong HG, Kim D, Kim DY, Yang W, et al. Ceria-zirconia nanoparticles as an enhanced multi-antioxidant for sepsis treatment. Angew Chem Int Ed Engl. 2017;56(38):11399\u2013403.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"7","key":"1318_CR32","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1166\/jbn.2020.2948","volume":"16","author":"SE Hong","year":"2020","unstructured":"Hong SE, An JH, Yu SL, Kang J, Park CG, Lee HY, et al. Ceria-zirconia antioxidant nanoparticles attenuate hypoxia-induced acute kidney injury by restoring autophagy flux and alleviating mitochondrial damage. J Biomed Nanotechnol. 2020;16(7):1144\u201359.","journal-title":"J Biomed Nanotechnol"},{"issue":"40","key":"1318_CR33","doi-asserted-by":"publisher","first-page":"14144","DOI":"10.1021\/ja9051087","volume":"131","author":"AS Karakoti","year":"2009","unstructured":"Karakoti AS, Singh S, Kumar A, Malinska M, Kuchibhatla SV, Wozniak K, et al. PEGylated nanoceria as radical scavenger with tunable redox chemistry. J Am Chem Soc. 2009;131(40):14144\u20135.","journal-title":"J Am Chem Soc"},{"issue":"3","key":"1318_CR34","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1681\/ASN.V133630","volume":"13","author":"MA Saleem","year":"2002","unstructured":"Saleem MA, O\u2019Hare MJ, Reiser J, Coward RJ, Inward CD, Farren T, et al. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol. 2002;13(3):630\u20138.","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"1318_CR35","doi-asserted-by":"publisher","first-page":"e0219483","DOI":"10.1371\/journal.pone.0219483","volume":"14","author":"S Cho","year":"2019","unstructured":"Cho S, Yu SL, Kang J, Jeong BY, Lee HY, Park CG, et al. NADPH oxidase 4 mediates TGF-beta1\/Smad signaling pathway induced acute kidney injury in hypoxia. PLoS ONE. 2019;14(7):e0219483.","journal-title":"PLoS ONE"},{"issue":"4","key":"1318_CR36","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1093\/jac\/dkx479","volume":"73","author":"BY Jeong","year":"2018","unstructured":"Jeong BY, Park SR, Cho S, Yu SL, Lee HY, Park CG, et al. TGF-beta-mediated NADPH oxidase 4-dependent oxidative stress promotes colistin-induced acute kidney injury. J Antimicrob Chemother. 2018;73(4):962\u201372.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"1318_CR37","doi-asserted-by":"publisher","first-page":"e0191034","DOI":"10.1371\/journal.pone.0191034","volume":"13","author":"BY Jeong","year":"2018","unstructured":"Jeong BY, Lee HY, Park CG, Kang J, Yu SL, Choi DR, et al. Oxidative stress caused by activation of NADPH oxidase 4 promotes contrast-induced acute kidney injury. PLoS ONE. 2018;13(1):e0191034.","journal-title":"PLoS ONE"},{"issue":"1","key":"1318_CR38","doi-asserted-by":"publisher","first-page":"E120","DOI":"10.3390\/molecules21010120","volume":"21","author":"YJ Lee","year":"2016","unstructured":"Lee YJ, Cui J, Lee J, Han AR, Lee EB, Jang HH, et al. Cytotoxic compounds from Juglans sinensis Dode display anti-proliferative activity by inducing apoptosis in human cancer cells. Molecules. 2016;21(1):E120.","journal-title":"Molecules"},{"issue":"6","key":"1318_CR39","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1073\/pnas.94.6.2540","volume":"94","author":"T Ohshima","year":"1997","unstructured":"Ohshima T, Murray GJ, Swaim WD, Longenecker G, Quirk JM, Cardarelli CO, et al. alpha-galactosidase A deficient mice: a model of Fabry disease. Proc Natl Acad Sci U S A. 1997;94(6):2540\u20134.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"1318_CR40","doi-asserted-by":"publisher","first-page":"e108641","DOI":"10.1371\/journal.pone.0108641","volume":"9","author":"J Lakoma","year":"2014","unstructured":"Lakoma J, Rimondini R, Donadio V, Liguori R, Caprini M. Pain related channels are differentially expressed in neuronal and non-neuronal cells of glabrous skin of fabry knockout male mice. PLoS ONE. 2014;9(10):e108641.","journal-title":"PLoS ONE"},{"issue":"6","key":"1318_CR41","doi-asserted-by":"publisher","first-page":"335","DOI":"10.5692\/clinicalneurol.cn-001246","volume":"59","author":"T Ohashi","year":"2019","unstructured":"Ohashi T. Current status and future prospect of enzyme replacement therapy for Fabry disease. Rinsho Shinkeigaku. 2019;59(6):335\u20138.","journal-title":"Rinsho Shinkeigaku"},{"issue":"8","key":"1318_CR42","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1080\/15548627.2018.1474314","volume":"14","author":"M Mauthe","year":"2018","unstructured":"Mauthe M, Orhon I, Rocchi C, Zhou X, Luhr M, Hijlkema KJ, et al. Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion. Autophagy. 2018;14(8):1435\u201355.","journal-title":"Autophagy"},{"issue":"3","key":"1318_CR43","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1681\/ASN.2011070690","volume":"23","author":"DP Cina","year":"2012","unstructured":"Cina DP, Onay T, Paltoo A, Li C, Maezawa Y, De Arteaga J, et al. Inhibition of MTOR disrupts autophagic flux in podocytes. J Am Soc Nephrol. 2012;23(3):412\u201320.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"1318_CR44","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1080\/15548627.2018.1511504","volume":"15","author":"IC Nnah","year":"2019","unstructured":"Nnah IC, Wang B, Saqcena C, Weber GF, Bonder EM, Bagley D, et al. TFEB-driven endocytosis coordinates MTORC1 signaling and autophagy. Autophagy. 2019;15(1):151\u201364.","journal-title":"Autophagy"},{"issue":"2","key":"1318_CR45","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.it.2019.12.003","volume":"41","author":"JE Irazoqui","year":"2020","unstructured":"Irazoqui JE. Key roles of MiT transcription factors in innate immunity and inflammation. Trends Immunol. 2020;41(2):157\u201371.","journal-title":"Trends Immunol"},{"issue":"2","key":"1318_CR46","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1161\/ATVBAHA.120.315310","volume":"41","author":"J Sun","year":"2021","unstructured":"Sun J, Lu H, Liang W, Zhao G, Ren L, Hu D, et al. Endothelial TFEB (transcription factor EB) improves glucose tolerance via upregulation of IRS (insulin receptor substrate) 1 and IRS2. Arterioscler Thromb Vasc Biol. 2021;41(2):783\u201395.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"1318_CR47","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ymgme.2008.06.016","volume":"95","author":"JS Shen","year":"2008","unstructured":"Shen JS, Meng XL, Moore DF, Quirk JM, Shayman JA, Schiffmann R, et al. Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells. Mol Genet Metab. 2008;95(3):163\u20138.","journal-title":"Mol Genet Metab"},{"issue":"3","key":"1318_CR48","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3727\/096368916X694265","volume":"26","author":"WL Tseng","year":"2017","unstructured":"Tseng WL, Chou SJ, Chiang HC, Wang ML, Chien CS, Chen KH, et al. Imbalanced production of reactive oxygen species and mitochondrial antioxidant SOD2 in Fabry disease-specific human induced pluripotent stem cell-differentiated vascular endothelial cells. Cell Transplant. 2017;26(3):513\u201327.","journal-title":"Cell Transplant"},{"issue":"4","key":"1318_CR49","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/jmri.20162","volume":"20","author":"DF Moore","year":"2004","unstructured":"Moore DF, Ye F, Brennan ML, Gupta S, Barshop BA, Steiner RD, et al. Ascorbate decreases Fabry cerebral hyperperfusion suggesting a reactive oxygen species abnormality: an arterial spin tagging study. J Magn Reson Imaging. 2004;20(4):674\u201383.","journal-title":"J Magn Reson Imaging"},{"issue":"11","key":"1318_CR50","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1212\/01.wnl.0000247278.88077.09","volume":"67","author":"CR Kaneski","year":"2006","unstructured":"Kaneski CR, Moore DF, Ries M, Zirzow GC, Schiffmann R. Myeloperoxidase predicts risk of vasculopathic events in hemizgygous males with Fabry disease. Neurology. 2006;67(11):2045\u20137.","journal-title":"Neurology"},{"issue":"1\u20132","key":"1318_CR51","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.cca.2005.07.022","volume":"364","author":"FM Roversi","year":"2006","unstructured":"Roversi FM, Galdieri LC, Grego BH, Souza FG, Micheletti C, Martins AM, et al. Blood oxidative stress markers in Gaucher disease patients. Clin Chim Acta. 2006;364(1\u20132):316\u201320.","journal-title":"Clin Chim Acta"},{"issue":"2\u20133","key":"1318_CR52","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ymgme.2010.06.018","volume":"101","author":"R Fu","year":"2010","unstructured":"Fu R, Yanjanin NM, Bianconi S, Pavan WJ, Porter FD. Oxidative stress in Niemann-Pick disease, type C. Mol Genet Metab. 2010;101(2\u20133):214\u20138.","journal-title":"Mol Genet Metab"},{"issue":"25","key":"1318_CR53","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1056\/NEJMra1106556","volume":"365","author":"VD D'Agati","year":"2011","unstructured":"D\u2019Agati VD, Kaskel FJ, Falk RJ. Focal segmental glomerulosclerosis. N Engl J Med. 2011;365(25):2398\u2013411.","journal-title":"N Engl J Med"},{"issue":"6","key":"1318_CR54","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1093\/ndt\/gfq306","volume":"26","author":"MD Sanchez-Nino","year":"2011","unstructured":"Sanchez-Nino MD, Sanz AB, Carrasco S, Saleem MA, Mathieson PW, Valdivielso JM, et al. Globotriaosylsphingosine actions on human glomerular podocytes: implications for Fabry nephropathy. Nephrol Dial Transplant. 2011;26(6):1797\u2013802.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"1318_CR55","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/ckj\/sfy053","volume":"12","author":"H Trimarchi","year":"2019","unstructured":"Trimarchi H, Canzonieri R, Costales-Collaguazo C, Politei J, Stern A, Paulero M, et al. Early decrease in the podocalyxin to synaptopodin ratio in urinary Fabry podocytes. Clin Kidney J. 2019;12(1):53\u201360.","journal-title":"Clin Kidney J"},{"issue":"5","key":"1318_CR56","doi-asserted-by":"publisher","first-page":"301","DOI":"10.5414\/CN108317","volume":"83","author":"N Takahashi","year":"2015","unstructured":"Takahashi N, Yokoi S, Kasuno K, Kogami A, Tsukimura T, Togawa T, et al. A heterozygous female with Fabry disease due to a novel alpha-galactosidase A mutation exhibits a unique synaptopodin distribution in vacuolated podocytes. Clin Nephrol. 2015;83(5):301\u20138.","journal-title":"Clin Nephrol"},{"issue":"20","key":"1318_CR57","doi-asserted-by":"publisher","first-page":"e1907322","DOI":"10.1002\/smll.201907322","volume":"16","author":"E Casals","year":"2020","unstructured":"Casals E, Zeng M, Parra-Robert M, Fernandez-Varo G, Morales-Ruiz M, Jimenez W, et al. Cerium oxide nanoparticles: advances in biodistribution, toxicity, and preclinical exploration. Small. 2020;16(20):e1907322.","journal-title":"Small"},{"issue":"5","key":"1318_CR58","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.ajps.2019.10.005","volume":"15","author":"B Stephen Inbaraj","year":"2020","unstructured":"Stephen Inbaraj B, Chen BH. An overview on recent in vivo biological application of cerium oxide nanoparticles. Asian J Pharm Sci. 2020;15(5):558\u201375.","journal-title":"Asian J Pharm Sci"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-022-01318-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-022-01318-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-022-01318-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T16:23:42Z","timestamp":1700324622000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-022-01318-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,9]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1318"],"URL":"https:\/\/doi.org\/10.1186\/s12951-022-01318-8","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,9]]},"assertion":[{"value":"15 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All mice were kept in the specific pathogen-free laboratory, and the experimental procedures were approved by the Institutional Lab Animal Care and Use Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors do not have any possible conflict of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"125"}}